Inventaire - your friends and communities are your best library

In silico pharmacogenetics of warfarin metabolism.

author

Steven Shafer

published in: Nature Biotechnology

date of publication: 2006-05-01

main subject: (RS)-warfarin

Cites articles 27

Date

Title

Authors

2005-09-01

Computational genetics: from mouse to human?
2005-06-01

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

Deborah A Nickerson
2004-10-01

In silico genetics: identification of a functional element regulating H2-Ealpha gene expression

John McPherson
2004-09-15

Identification of glutathione-derived metabolites from an IP receptor antagonist
2004-10-01

Determination of phenprocoumon, warfarin and their monohydroxylated metabolites in human plasma and urine by liquid chromatography-mass spectrometry after solid-phase extraction

Anders Rane, Mike Ufer
2003-05-01

Pharmacogenetics of oral anticoagulants.

Ann K Daly
2001-11-01

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review
2001-11-01

Quantitative liquid chromatography/mass spectrometry/mass spectrometry warfarin assay for in vitro cytochrome P450 studies
2001-07-01

Oxidative hydrolysis of scoparone by cytochrome p450 CYP2C29 reveals a novel metabolite

Christoph E. Hagemeyer
1999-11-01

The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future
1999-10-01

Pharmacogenomics: translating functional genomics into rational therapeutics
1998-09-01

Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid
1997-01-01

Human P450 metabolism of warfarin
1996-09-01

Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes
1995-07-01

cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification

Jeroen Buters
1995-12-01

Human cytochromes P4501A1 and P4501A2: R-warfarin metabolism as a probe
1994-02-01

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
1993-03-01

High clearance of (S)-warfarin in a warfarin-resistant subject
1993-03-01

Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075)
1992-01-01

Phase II metabolism of warfarin in primary culture of adult rat hepatocytes
1992-08-01

Factors affecting the maintenance dose of warfarin
1990-09-01

Analysis of phenprocoumon and its hydroxylated and conjugated metabolites in human urine by high-performance liquid chromatography after solid-phase extraction
1987-01-01

The biochemical basis of warfarin therapy
1974-07

Vitamin K dependent modifications of glutamic acid residues in prothrombin,Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin
1974-10-01

The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin
1964-07-01

THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE
Haplotype Structure of the Mouse Genome

Article - wd:Q41894196

Welcome to Inventaire

the library of your friends and communities

learn more